S Gauthier Selected Research

S Gauthier Research Topics

Disease

43	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 01/2000
12	Dementia (Dementias) 01/2023 - 01/2000
6	Cognitive Dysfunction 01/2022 - 01/2000
4	Inflammation (Inflammations) 01/2023 - 01/2001
3	Breast Neoplasms (Breast Cancer) 01/2016 - 02/2000
2	Neuroinflammatory Diseases 01/2023 - 01/2022
2	Atrophy 01/2022 - 06/2009
2	Disease Progression 01/2017 - 11/2013
2	Nausea 09/2008 - 05/2008
2	Hallucinations (Hallucination) 05/2008 - 12/2005
1	Urolithiasis 09/2020
1	Pain (Aches) 09/2020
1	Pyelonephritis 09/2020
1	Amyloid Plaque 01/2016
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2016
1	Edema (Dropsy) 01/2016
1	Tuberculosis (Tuberculoses) 01/2016
1	Colonic Neoplasms (Colon Cancer) 01/2014
1	Amyloidosis 01/2014
1	Interstitial Lung Diseases (Interstitial Lung Disease) 04/2012
1	Melanoma (Melanoma, Malignant) 04/2012
1	Multiple Sclerosis 08/2010
1	Vomiting 09/2008
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 09/2008
1	REM Sleep Behavior Disorder 12/2005
1	Sleep Wake Disorders 12/2005
1	Mental Disorders (Mental Disorder) 11/2005
1	Ovarian Epithelial Carcinoma 10/2003
1	Nervous System Diseases (Neurological Disorders) 08/2001
1	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2001
1	Anemia 12/2000
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2000
1	Prostatic Neoplasms (Prostate Cancer) 02/2000
1	Hirsutism 02/2000
1	Alopecia (Baldness) 02/2000
1	Acne Vulgaris 02/2000
1	Neoplasms (Cancer) 02/2000
1	Seborrheic Dermatitis 02/2000

Drug/Important Bio-Agent (IBA)

11	Amyloid (Amyloid Fibrils)IBA 01/2024 - 03/2001
8	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2013
7	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2016 - 01/2000
4	Amyloid beta-PeptidesIBA 01/2023 - 08/2001
4	tramiprosateIBA 01/2017 - 04/2009
4	Memantine (Namenda)FDA Link 01/2016 - 05/2005
4	Donepezil (Aricept)FDA LinkGeneric 08/2007 - 08/2001
3	Apolipoprotein E4IBA 01/2017 - 01/2016
3	Rivastigmine (Exelon)FDA LinkGeneric 10/2008 - 12/2000
2	Cholinergic Agents (Cholinergics)IBA 11/2017 - 01/2001
2	tau Proteins (tau Protein)IBA 01/2017 - 01/2016
2	Cytostatic AgentsIBA 04/2012 - 02/2000
2	Galantamine (Galanthamine)FDA LinkGeneric 09/2008 - 05/2008
2	ApolipoproteinsIBA 01/2003 - 03/2001
1	hydromethylthionineIBA 01/2022
1	Morphine (MS Contin)FDA LinkGeneric 09/2020
1	N-Methylaspartate (NMDA)IBA 01/2016
1	Caseins (Casein)FDA Link 01/2014
1	fotemustine (Muphoran)IBA 04/2012
1	Dacarbazine (DIC)FDA LinkGeneric 04/2012
1	HLA-DRB1 Chains (HLA DRB1)IBA 08/2010
1	HLA-C Antigens (HLA-C)IBA 08/2010
1	HLA-B Antigens (HLA-B)IBA 08/2010
1	HLA-A Antigens (HLA-A)IBA 08/2010
1	alzhemedIBA 04/2009
1	Levodopa (L Dopa)FDA LinkGeneric 12/2005
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 12/2005
1	Antipsychotic Agents (Antipsychotics)IBA 12/2005
1	Cisplatin (Platino)FDA LinkGeneric 10/2003
1	Gemcitabine FDA Link 10/2003
1	Apolipoproteins E (ApoE)IBA 01/2003
1	cerebrolysinIBA 07/2002
1	AntioxidantsIBA 08/2001
1	Free RadicalsIBA 03/2001
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2001
1	Proteins (Proteins, Gene)FDA Link 03/2001
1	PresenilinsIBA 03/2001
1	CalciumIBA 02/2001
1	Glucose (Dextrose)FDA LinkGeneric 02/2001
1	ElectrolytesIBA 02/2001
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2001
1	IronIBA 12/2000
1	Verapamil (Calan)FDA LinkGeneric 11/2000
1	AnthracyclinesIBA 11/2000
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 11/2000
1	Vitamin E FDA LinkGeneric 09/2000
1	bicalutamide (Casodex)FDA LinkGeneric 02/2000
1	Estrone FDA Link 02/2000
1	nilutamide (Nilandron)FDA Link 02/2000
1	AndrogensIBA 02/2000
1	GlucocorticoidsIBA 02/2000
1	Estrogen Receptor Modulators (Antiestrogen)IBA 02/2000
1	EM 800IBA 02/2000
1	Flutamide (Eulexin)FDA LinkGeneric 02/2000

Therapy/Procedure

8	Activities of Daily Living (ADL) 01/2022 - 01/2000
7	Therapeutics 01/2019 - 02/2000
2	Drug Therapy (Chemotherapy) 07/2001 - 11/2000
1	Denervation 11/2017
1	Assisted Suicide (Physician Assisted Suicide) 01/2017
1	Injections 07/2002
1	Castration 02/2000
1	Prostatectomy (Retropubic Prostatectomy) 02/2000